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Abstract
Background:  Cocaine and amphetamine regulated transcript (CART) is an anorectic
neuropeptide located principally in hypothalamus. CART has been shown to be involved in control
of feeding behavior, but a direct relationship with obesity has not been established. The aim of this
study was to evaluate the effect of polymorphisms within the CART gene with regards to a possible
association with obesity in a Caucasian population.
Results: Screening of the entire gene as well as a 3.7 kb region of 5' upstream sequence revealed
31 SNPs and 3 rare variants ; 14 of which were subsequently genotyped in 292 French morbidly
obese subjects and 368 controls. Haplotype analysis suggested an association with obesity which
was found to be mainly due to SNP-3608T>C (rs7379701) (p = 0.009). Genotyping additional cases
and controls also of European Caucasian origin supported further this possible association between
the CART SNP -3608T>C T allele and obesity (global p-value = 0.0005). Functional studies also
suggested that the SNP -3608T>C could modulate nuclear protein binding.
Conclusion: CART SNP -3608T>C may possibly contribute to the genetic risk for obesity in the
Caucasian population. However confirmation of the importance of the role of the CART gene in
energy homeostasis and obesity will require investigation and replication in further populations.
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Background
Cocaine and amphetamine regulated transcript (CART) is
a potent anorectic peptide that is widely expressed in
hypothalamic areas and is involved in the control of feed-
ing behavior [1,2]. Immunohistochemistry studies show
that CART peptides co-localize with both anorectic and
orexigenic hypothalamic peptides [3], particularly with
pro-opiomelanocortin (POMC), in the arcuate nucleus
(ARC) [4]. Moreover, CART peptides are distributed in
peripheral organs notably in the D cells of the endocrine
pancreas [5,6] and throughout the peripheral nervous sys-
tem within the vagal efferent neurons, where it interacts
with cholecystokinin [7]. Leptin regulates CART mRNA
expression, since it is reduced in the arcuate nucleus by the
disruption of leptin signaling (in ob/ob mice or fa/fa rats)
and increased by leptin peripheral injections [8]. Recent
studies have shown that in the context of a high fat diet
there is a close relationship between CART and leptin
which facilitates the regulation of lipid metabolism in
order to control body fat [9]. In rodents, intracerebroven-
tricular injection (ICV) of CART peptide fragments inhib-
its feeding and antagonizes the feeding response induced
by the orexigenic neuropeptide Y (NPY), whereas ICV
injection of CART antiserum is found to stimulate feeding
[3]. However, instead of the expected hyperphagic pheno-
type, CART-deficient mice are predisposed to obesity only
when fed with a calorie-rich diet [10]. Although CART has
therefore been shown to be involved in control of feeding
behavior, a direct relationship with obesity has not yet
been established.
Earlier studies have failed to detect an association between
exonic  CART  gene single nucleotide polymorphisms
(SNPs) and obesity or obesity-related phenotypes [11-
13]. Recently, however, a putative CART promoter SNP (-
156A>G) has been reported as having a possible associa-
tion with obesity in a Japanese population [14]. Interest-
ingly, CART maps to chromosome 5q13.2, 4.8 Mb from
the D5S647 locus, a region previously linked to obesity
and serum leptin levels in obese French Caucasian fami-
lies [15]. CART is located 61.8 kb downstream the MCCC2
gene (methylcrotonoyl-Coenzyme A carboxylase 2) and is
distant to 386 Kb from the MAP1B gene (microtubule-
associated protein 1B). Only CART gene is recognized as
candidate for obesity. Recent data have suggested that
restricting SNPs analysis to the coding regions only does
not adequately describe all the common haplotypes or the
true haplotype block structure observed when all of the
common variations within the genetic region are used to
infer haplotypes [16]. Thus, in this study's investigation of
the genetic contribution of CART to obesity a region that
included the three exons, as well as the two introns and
the 5' region from the first ATG to 3.7 kb upstream was
screened for SNPs. The initial case-control study was per-
formed in 292 morbidly obese French subjects (BMI ≥  40
kg/m2) and 368 non-obese and normoglycemic controls.
In a subsequent extension in the investigation the previ-
ously associated SNPs were genotyped in additional sam-
ple sets of cases and controls and a haplotype analysis was
performed to identify potentially functional SNPs.
Results
Initial case-control study
To investigate variation within CART, a genetic region of
5.4 kb was sequenced in a total of forty-five subjects (39
obese and six non-obese individuals). A total of thirty-
four SNPs were identified (Figure 1) [see Additional file
1]. Three SNPs : a missense Glu32Lys mutation (+94G>A)
in exon 1, as well as IVS1+114C>T and IVS1-31C>T both
of which resided in intron 1, presented with a frequency
lower than 1% (data not shown). None of these rare SNPs
were found to co-segregate with obesity or obesity related
phenotypes in the probands' families (data not shown).
Using the analysis of these thirty-one frequent SNPs (fre-
quency>3%), in this group of forty-five subjects, the link-
age disequilibrium (LD) was calculated using the GOLD
program (Figure 2). Thus, among the thirty-one SNPs,
fourteen SNPs were found to be non-redundant and were
subsequently genotyped in 292 morbidly obese subjects
and 368 controls. In the 5' region, three SNPs (-3608T>C,
-1702C>T and -175A>G) were found to be significantly
associated with obesity (p = 0.001; p = 0.0015; p = 0.002 ;
see Table 1). A weak association was observed for the
3'UTR SNP +1343delA (p  = 0.02) and for the 5' SNP-
3607C>T (p = 0.046). The 14 SNPs were consistent with
the Hardy-Weinberg equilibrium (HWE) in the obese
group, although in controls, SNP-3608T>C, SNP-
3607C>T, SNP-1702C>T, SNP-175A>G deviated from
HWE (p = 0.0017; p = 0.002; p = 0.0016 and p = 0.0017
respectively). In addition, allele frequency differences
between obese and non-obese subjects were confirmed
with the Armitage's trend test [17], which doesn't rely on
the Hardy-Weinberg equilibrium hypothesis. Neverthe-
less the genotyping accuracy for these SNPs was subse-
quently confirmed by duplicate direct sequencing in all
those individuals.
The genotyping of the five SNPs potentially associated
with obesity (5' SNPs : -3608T>C, -3607C>T, -1702C>T, -
175A>G and 3'UTR SNP: +1343delA) was then extended
to an additional set of 329 morbidly obese subjects. This
second French population was not significantly different
in mean age or BMI in comparison to the first and there-
fore enabled pooling of the two case cohorts and the com-
parison of the SNP allele frequencies between a total of
621 morbidly obese subjects and 368 controls. The -
3608T, the -3607C, the -1702T, the -175A and the
+1343delA alleles were still more frequent in the morbid
obese subjects than in the controls : OR = 1.33, 95%CI =
[1.11–1.61], p  = 0.002 ; OR = 1.21, 95%CI = [1.004–BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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1.45], p = 0.046 ; OR = 1.35, 95%CI = [1.11–1.64], p =
0.002 ; OR = 1.30, 95%CI = [1.07–1.57], p = 0.007 and
OR = 1.50, 95%CI = [1.07–2.10], p = 0.017 respectively,
see Table 1). The results with the most significant p-value
of 0.002, which was observed for the SNPs -3608T>C and
-1702C>T, was only reached seven times on 1000 permu-
tations, confirming the strength of this result, even though
multiple testing was performed.
Haplotype analysis
The fourteen SNPs were further submitted to haplotype
analysis. Rare haplotypes (frequencies < 0.02) were
removed. Considering 94.4 % of the existing haplotypes,
seven SNPs were identified, which are structured in two
combinations of six SNPs (SNPs -3608T>C/ -1705C>T/ -
1702C>T/ -1474T>C/ -271C>T/ +1343delA) and (-
175A>G/ -1705C>T/ -1702C>T/ -1474T>C/ -271C>T/
+1343delA) represented the haplotype information the
best. Haplotype frequencies were compared between the
292 morbidly obese subjects and the 368 controls using
the THESIAS (Testing Haplotype Effects in Association Stud-
ies) software [18]. Both combinations displayed associa-
tion with obesity (p = 0.0003). Then, investigating the
effect of individual or group of SNPs on the general hap-
lotypic model, it was observed that the significant effect
on obesity was mainly due to i) two combinations of pro-
moter SNPs : (-3608T>C/ -1702C>T) and (-1702C>T/ -
175A>G) (p = 0.0002 for both combinations) and ii) the
presence of the SNP+1343delA (p = 0.002). The two com-
binations (-3608T>C/ -1702C>T/ +1343delA and -
1702C>T/ -175A>G/ +1343delA) were analyzed in the
621 morbidly obese subjects and in the 368 controls and
were found to show an association with obesity (global p
= 6.10-5). The haplotypes including SNPs -3608T (or -
175A), -1702T, +1343A alleles or -3608C (or -175G), -
1702C, +1343delA were more frequent in obese subjects
than in controls (10.9% vs. 7.2%, OR = 1.91, 95%CI =
[1.18–3.12],  p  = 0.009; 44.0% vs. 35.6%, OR = 1.60,
95%CI = [1.26–2.03], p = 0.0001 respectively).
These analyses were then implemented in the
COCAPHASE program to exclude putative errors in hap-
lotype determination induced by the Hardy Weinberg dis-
equilibrium observed in the controls, which confirmed
the results obtained with THESIAS (data not shown).
Altogether, these data highlighted the role of SNPs -
3608T>C (or -175A>G), and -1702C>T combined to
SNP+1343delA in the SNP haplotype structure associated
with obesity in French Caucasians.
Study of SNPs -3608T>C, -1702C>T,-175A>G and 
+1343delA in a French general population
In order to support further our initial findings, we ana-
lyzed an independent control group consisting of 732
non obese subjects ascertained from the general French
population. All SNPs did not deviate from HWE in this
group. When this control group was compared to the 621
French morbid obese subjects, SNP-3608T>C showed a
nominal association with morbid obesity (OR = 1.18,
95%CI = [1.01–1.39], p = 0.038), although the SNPs -
1702C>T, -175A>G and +1343delA were not found to be
associated with obesity (data not shown). The prevalence
of the SNP -3608C>T T allele was 49.4% in morbidly
obese subjects, 45.2% in controls derived from the French
general population and 42.3% in the non obese and nor-
moglycemic subjects (Figure 3).
SNPs map of the CART gene Figure 1
SNPs map of the CART gene. SNPs are reported assigning +1 to the A of the ATG start codon. The numbering reported in the 
literature is given in parentheses.BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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Study of SNP-3608T>C in morbid Swiss and moderate 
French obese subjects
To further investigate the impact of the 3608T>C CART
SNP on obesity in populations of European origin, we
extended the study to 619 additional French subjects with
moderate obesity (30 kg/m2<BMI<40 kg/m2) and to 385
morbidly obese Swiss subjects (BMI>40 kg/m2). As shown
in Figure 3, no significant difference in the T allele fre-
quency was found between the two obese groups or with
the initial 621 morbidly obese subjects, thus confirming
the high prevalence of this allele in association with obes-
ity. When the three obese group (n = 1,625) and the two
control groups (n = 1,100) were analyzed together, an
association with obesity and the CART 3608T>C T allele
was confirmed (OR = 1.22, 95%CI = [1.09–1.37], p =
0.0005).
Pairwise linkage disequilibrium between the 31 SNPs of CART gene in 45 subjects Figure 2
Pairwise linkage disequilibrium between the 31 SNPs of CART gene in 45 subjects. The LD was measured by delta (color scale) 
using the Gold software. SNPs are indicated along the horizontal and vertical axes, according to the first transcribed nucleotide 
position. Underlined SNPs were selected for the initial case-control study. Regions of high and low linkage disequilibrium are 
represented by red and blue shading, respectively.BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
Page 5 of 12
(page number not for citation purposes)
Electrophoretic mobility shift assays (EMSAs) analysis
Therefore genetic studies suggested an association
between  CART  SNP-3608C>T and obesity. These data
then promoted the investigation of this polymorphism's
potential functional effect. Potential effects of plausible
promoter SNP -3608T>C on binding affinity for nuclear
proteins was evaluated by electrophoretic mobility shift
assays (EMSA) in RIN-1027-B2 cells. This cell line was
chosen because CART expression has been localized in the
somatostatin producing islet D pancreatic cells. As SNP -
3607C>T is adjacent to SNP -3608T>C, two pairs of DNA
oligonucleotide probes were required. In the presence of -
3607C, RIN-1027-B2 nuclear proteins (Figure 4, band 2)
have a lower affinity for the C allele than the T allele of
Table 1: Alleles and genotype distributions for five CART SNPs in 368 French non-obese group and in different French morbid obese 
groups.
SNPs allelesa p-valueb OR [95%CI] genotypesa p-valuec
-3608T>C T C TT TC CC
French non-obese subjects 311 (42.3) 425 (57.7) 51 (13.9) 209 (56.8) 108 (29.3)
1st set of French morbid obese subjects 299 (51.4) 283 (48.6) 0.001 1.44 [1.16–1.80] 78 (26.8) 143 (49.1) 70 (24.1) 0.0006
2nd set of French morbid obese subjects 287 (47.5) 317 (52.5) 0.05 1.24 [1.00–1.54] 65 (21.5) 157 (52.0) 80 (26.5) 0.04
Pooled set of French morbid obese 
subjects*
586 (49.4) 600 (50.6) 0.002 1.33 [1.11–1.61] 143 (24.1) 300 (50.6) 150 (25.3) 0.001
-3607C>T C T CC CT TT
French non-obese subjects 392 (53.3) 344 (46.7) 90 (24.5) 212 (57.6) 66 (17.9)
1st set of French morbid obese subjects 342 (58.8) 240 (41.2) 0.046 1.33 [1.11–1.61] 102 (35.1) 138 (47.4) 51 (17.5) 0.037
2nd set of French morbid obese subjects 346 (57.1) 260 (42.9) 0.16 1.17 [0.94–1.45] 100 (33.0) 146 (48.2) 57 (18.8) 0.14
Pooled set of French morbid obese 
subjects
688 (57.9) 500 (42.1) 0.046 1.21 [1.004–1.45] 202 (34.0) 284 (47.8) 108 (18.2) 0.04
-1702C>T C T CC CT TT
French non-obese subjects 438 (63.3) 254 (36.7) 125 (36.1) 188 (54.3) 33 (9.6)
1st set of French morbid obese subjects 306 (54.4) 256 (45.6) 0.0015 1.44 [1.15–1.81] 82 (29.2) 142 (50.5) 57 (20.3) 0.0009
2nd set of French morbid obese subjects 345 (57.7) 253 (42.3) 0.04 1.27 [1.01–1.58] 94 (31.4) 157 (52.5) 48 (16.1) 0.028
Pooled set of French morbid obese 
subjects
651 (56.1) 509 (43.9) 0.002 1.35 [1.11–1.64] 176 (30.3) 299 (51.6) 105 (18.1) 0.0015
-175A>G A G AA AG GG
French non-obese subjects 294 (42.4) 400 (57.6) 48 (13.8) 198 (57.1) 101 (29.1)
1st set of French morbid obese subjects 279 (51.1) 267 (48.9) 0.0022 1.42 [1.13–1.78] 72 (26.4) 135 (49.4) 66 (24.2) 0.0014
2nd set of French morbid obese subjects 289 (46.8) 329 (53.2) 0.10 1.19 [0.96–1.49] 69 (22.3) 151 (48.9) 89 (28.8) 0.095
Pooled set of French morbid obese 
subjects
568 (48.8) 596 (51.2) 0.007 1.30 [1.07–1.57] 141 (24.2) 286 (49.1) 155 (26.7) 0.006
+1343delA A delA AA AdelA delAdelA
French non-obese subjects 656 (92.7) 52 (7.3) 304 (85.9) 48 (13.6) 2 (0.5)
1st set of French morbid obese subjects 520 (89.1) 64 (10.9) 0.02 1.53 [1.06–2.28] 232 (79.4) 56 (19.2) 4 (1.4) 0.02
2nd set of French morbid obese subjects 590 (89.6) 68 (10.4) 0.05 1.45 [1.00–2.12] 263 (80.0) 64 (19.4) 2 (0.6) 0.048
Pooled set of French morbid obese 
subjects
1110 (89.4) 132 (10.6) 0.017 1.50 [1.07–2.10] 495 (79.7) 120 (19.3) 6 (1.0) 0.017
aNumber of alleles or genotypes (frequencies, %)
b p-value corresponds to association analysis between different French morbidly obese groups (BMI ≥  40 kg/m2) and non-obese subjects (BMI<27 kg/
m2).
c p-value is calculated by the Armitage's trend test.
"Risk" alleles underlined are those encountered more frequently in obese groups.
* Pooled set of 621 French morbidly obese subjects were composed of the first set of 292 French morbidly obese patients (BMI = 47.5 ± 7.8 kg/m2, 
age = 44.7 ± 10.8 years) and of a second set of 329 French morbidly obese patients (BMI = 48.1 ± 7.1 kg/m2, age = 48.5 ± 10.5 years).BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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SNP-3608T>C (Figure 4, lane 6), indicating that the pres-
ence of both the -3608T and the -3607C alleles are
required for binding. With at least one C allele present for
SNP -3608T>C or SNP -3607C>T, a binding (band 1) was
observed and this was found to be then decreased two-
fold in the -3608T-3607T configuration (Figure 4, lane 9).
To identify which SNP loci correspond to which band,
homologous and heterologous competition with non-
labeled probes were used in EMSA (Figure 4, lanes 3, 4, 7,
8, 10, 11, 13, 14). The addition of either competitor -
3608T or -3608C induced a decrease of the two signals for
all configurations.
In silico analysis http://www.genomatix.de suggested that
allele -3608T could be located within at least three puta-
tive consensus sequences for transcription factor binding:
CHOP/GADD153 (C/EBP homologous protein), GATA-3
and OCT-1. Therefore, the presence of these transcription
factors in nuclear extracts from RIN-1027-B2 cells was
ascertained by performing western blot analysis with spe-
cific antibodies (Figure 5). As expression of CHOP was
increased by tunicamycin [19], EMSA experiments were
performed on nuclear extracts of treated cells. Results were
similar to those presented in Figure 4 (data not shown).
Then super-shift assays were performed with anti-GATA-3,
anti-OCT-1 antibodies on nuclear extracts from untreated
RIN-1027-B2 cells. For anti-CHOP antibody, nuclear
extracts were used from tunicamycin-treated and
untreated RIN-1027-B2 cells. In the presence of antibod-
ies the patterns of the super-shift assays did not differ
from those of the shift assays described in Figure 4 (four
replicates, data not shown). These results indicate that
none of these three transcription factors seemed to be
involved in the constitution of nuclear proteins – DNA
complexes including the -3608 locus observed in the
EMSA experiments.
Discussion
This is the first extensive study of the CART  gene that
includes an extensive analysis of the 5' region of the gene
(3.7 kb upstream) in association with human obesity.
Indeed, Dominguez et al. characterized the region encom-
Histogram summarized the -3608T allele frequency in different groups of controls and obese subjects Figure 3
Histogram summarized the -3608T allele frequency in different groups of controls and obese subjects. Compared to French 
controls from type 2 Diabetes pedigrees and French controls from general population ; -3608T allele frequency was more fre-
quent in the French moderate obese subjects (p = 0.011 and p = 0.14, respectively) and in the Swiss morbidly obese subjects (p 
= 0.002 and p = 0.078, respectively).BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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passing 3.4 kb of 5' upstream sequence in the mouse
CART gene and identified several regulation sites for
CART mRNA levels within this region [20]. CART is very
polymorphic in human : we found thirty-one common
SNPs and three rare variants (Figure 1). Of these, the
+1343delA (∆ A1457) and +1361A>G (A1475G) located
in the 3'UTR have been previously reported in Danish
subjects without association with obesity [11]. The
+1361A>G (A1475G) SNP was associated with a lower
waist-to-hip ratio in British Caucasian non-obese men
from the Isle of Ely type 2 diabetes cohort [12], but in our
French population showed no association with either
obesity or obesity-related phenotypes. In contrast to Fu et
al [21], no association between any CART SNPs and obes-
Electrophoretic mobility shift assays for SNP-3608T>C with nuclear extracts prepared from RIN-1027-B2 cells Figure 4
Electrophoretic mobility shift assays for SNP-3608T>C with nuclear extracts prepared from RIN-1027-B2 cells. Four probes 
used for EMSA contained respectively -3608T-3607C, -3608C-3607C, -3608T-3607T and -3608C-3607T. Specific complex for-
mations (compared lines 2 and 5) are indicated by two arrows. Lane 1 is radiolabeled probes without nuclear extract. In the 
presence of the -3608T allele and the -3607C allele, two bands (bands 1 and 2) were observed corresponding to the fixation of 
two different factors (lane 2). The intensity of the band 2 decreased when either of these two alleles was changed (lanes 6, 9 
and 12 compared to lane 2). The band 2 decreased by 1.5 fold in a TT or a CT configuration (lanes 9 and 12) and completely 
disappeared in a CC configuration at both loci (lane 6). The intensity of the band 1 and 2 was decreased when non radioactive 
competitors (either C or T alleles at the -3608 locus) were added to the reaction (lanes 3 and 4 compared to lane 2). In the TT 
configuration at the two loci, the addition of the -3608C non labeled probe did not decrease the band 2 signal unlike the -
3608T probe (lanes 10 and 11 compared to lane 9). These observations suggest that the band 2 corresponds to the binding of 
a putative nuclear protein when both the -3608T and the -3607C alleles are present. The band 1 was observed when at least 
one C allele was present at either locus, decreased by 2 fold in a TT configuration (lanes 2, 6, 12 compared to lane 9).BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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ity-related quantitative traits, like lipid levels, was
detected in our obese population (data not shown). Six
SNPs in the 5'flanking sequence covering a region of 1.1
Kb have been reported in Japanese obese subjects [14].
Instead of the -175G (-156G) allele being associated with
obesity in the Japanese obese population, the -175A (-
156A) wild type allele was more prevalent in obese than
in non-obese French subjects. This discordant result
between these two populations might be explained by
ethnic differences or a particular environmental influence.
Alternatively, it may only show that this SNP is not func-
tional, as suggested by the EMSA data that showed no pro-
tein-binding at this site (data not shown). Nevertheless,
discordance in allelic frequency between Caucasian and
Japanese populations has been previously observed for
other diabesity susceptibility genes, such as adiponectin/
APM1 [22].
Our study of the genetic variability of the CART gene in
various obese and control populations of European origin
suggests a possible association with obesity which is
mainly due to the effect of SNP -3608 T>C. We are aware
that the existence of Hardy-Weinberg disequilibrium (in
the first cohort of 368 French controls only) may lead to
an incorrect estimation of haplotype frequencies and thus
of the haplotype effect on obesity. Therefore we used
haplotype reconstruction algorithms that rely on the
hypothesis of random gamete association minimizing the
possible errors induced by absence of HWE. The deviation
from Hardy Weinberg equilibrium observed may have
several explanations. A random chance may account for
deviation from HWE in 1 out of 20 markers (5%) [23]. In
these present data, 50% of genotyped markers from the 5'
sequences of CART deviated from HWE thereby excluding
this hypothesis. The full replication of the initial SNP gen-
otypes by direct sequencing makes significant genotyping
errors unlikely. This deviation is also unlikely to be due to
hidden population structure since an excess of heterozy-
gote subjects was observed, whereas the effect of popula-
tion structure usually increases homozygote frequency in
the whole population [24]. To test whether departure
from HWE is specific to CART, we reanalyzed previous
genotyping data obtained in the 368 controls for eight
genes, some of them associated with obesity or associated
phenotypes such as UCP3, APM1, PGC1 and GAD2 genes.
No deviation from HWE was observed for any of the 27
SNPs from these genes [[22,25,26] and unpublished
data]. This would suggest a specific deviation of HWE in
the CART gene in the non-obese subjects of set 1. Devia-
tion from HWE may also be interpreted as a signal of asso-
ciation [23,27]. Unlike the 732 controls who are
representative of the French general population, the initial
cohort of 368 non-obese individuals resulted from a selec-
tion of non-obese normoglycemic subjects chosen from
French type 2 diabetes pedigrees. These subjects live in
families with type 2 diabetes where obesity is frequent,
and may therefore represent subjects more "resistant" to
both type 2 diabetes and obesity in spite of a shared com-
mon environment with their diabetic and/or obese family
members. The more significant association of SNPs -
3608T>C with obesity in this population compared to the
more general control population advocates the interest of
such a sample for an association study [28]. In addition,
the more robust association with morbid obesity high-
lights that the probability to detect genetic mutations
influencing BMI is higher in an obese population with a
more extreme phenotype.
EMSA experiments on SNP -3608T>C showed a func-
tional difference between the two alleles at the locus
where DNA variation modulates binding affinity in RIN-
1027-B2 pancreatic cells. However, we cannot clearly
ascertain the functional role of the SNP -3608T>C, since
Expression of nuclear proteins in untreated and tunicamycin- treated RIN-1027-B2 cells Figure 5
Expression of nuclear proteins in untreated and tunicamycin-
treated RIN-1027-B2 cells. GATA-3 and OCT-1 were specif-
ically detected in RIN-untreated cells (lanes 3 and 4). For 
CHOP, a multiple band pattern was observed (lane 1). As 
tunicamycin induces endoplasmic stress in cells and conse-
quently enhances CHOP expression, a western blot was per-
formed with tunicamycin treated RIN-1027-B2 cells to 
determine which band corresponds to CHOP. As pointed by 
the arrow, the intensity of the band of 27 KDa increased in 
nuclear extracts from RIN-treated cells, indicating that the 
amount of CHOP nuclear protein was increased (lane 2 com-
pared to lane 1).BMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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the nucleotide at position -3607 seems to interact with the
binding of nuclear factors. Moreover, haplotype analysis
comparing the 368 French controls and the 621 French
morbidly obese subjects, showed that the -3608T/-3607C
combination is associated with obesity (p = 0.0013).
Therefore, from our genetic and functional results, we
hypothesize that these two SNPs, located one base pair
apart, jointly modulate the binding of the same nuclear
factor on CART  gene 5' sequences. Nuclear factors
involved in the protein DNA complexes remain to be
identified. It also must be considered that functional
study in this cell line may or may not reflect all relevant
conditions in brain. So, cells from hypothalamic neurons
would allow confirmation of this observation and a better
understanding of plausible gene regulation.
Conclusion
This result concludes a possible modest contribution of
variation in the CART gene to the genetic susceptibility to
obesity. Replication in further populations will be
required to further strengthen this association.
Methods
Subjects
According to the previously reported linkage results at the
5q locus [15], we selected 45 subjects (39 obese and six
non-obese subjects) in families that contributed to the
linkage with obesity. The association study was performed
using at first a set of 368 non-obese and normoglycemic
subjects ([mean ± SD] age, 57.1 ± 13.5 years, BMI = 22.9
± 2.3 kg/m2, sex ratio : women/men 221/147) and a set of
292 morbidly obese French individuals (age, 44.7 ± 10.8
years, range 24 to 74, BMI = 47.5 ± 7.8 kg/m2, sex ratio :
women/men 232/60). SNPs showing a significant associ-
ation were genotyped in an extended set of 329 morbidly
obese French subjects (age, 48.5 ± 10.5 years, range 24 to
74, BMI = 48.1± 7.1 kg/m2, sex ratio : women/men 229/
100) from the same population as the first set of morbidly
French obese subjects were extracted from. The 385
severely obese subjects from Zurich, Switzerland that were
studied were consecutive, unrelated, Caucasian subjects
([mean ± SEM] age, 43.5 ± 0.5 years, range 24 to 69; BMI
= 43.4 ± 0.4 kg/m2; sex ratio : women/men 302/83)
referred to the ? clinic for refractory obesity from January
1999 to December 2000; informed written consent was
obtained [29]. The set of 619 moderately obese French
subjects were characterized as following: age 49.9 ± 13.4
years, range 24 to 88, BMI = 34.5 ± 2.9 kg/m2, sex ratio:
women/men 354/265. Two additional sets of control sub-
jects from the French general populations were studied :
546 subjects from the SUVIMAX population [30] ([mean
± SD] age 55 ± 6 years, BMI = 22 ± 1.8 kg/m2, sex ratio
women/men 246/300) and 186 subjects from the WHO-
MONICA Lille population [31] ([mean ± SD] age, 60.6 ±
3.1 years, BMI = 24.7 ± 2.9 kg/m2, sex ratio : women/men
98/88). Further analysis was performed by pooling these
data.
Screening and SNP map of the CART gene
We screened for SNPs in 3.7 kb of the plausible promoter
region, as well as the exons and the introns of the CART
gene by direct sequencing. PCR primers and annealing
temperatures are available from authors on request. The
protocol was carried out using the 96 capillary ABI
PRISM® 3700 DNA Analyzer (Applied Biosystems, Foster
City, CA) with the Big Dye Terminator Cycle Sequencing
Ready Reaction Kit, as previously described [32]. SNP
positions were assigned according to the A of the transla-
tion initiation codon (ATG ; Figure 1). The list of identi-
fied SNPs and corresponding rs numbers are presented in
the additional file (Table 2).
Genotyping
Several genotyping methods were used. E32K (+94G>A),
IVS1+114C>T, IVS1+224G>A and IVS1-31C>T were geno-
typed with PCR-RFLP using the Sac1, Blp1, Apa1 and
Mae3 restriction enzymes respectively (New England
Biolabs). Promoter fragments containing more than two
SNPs were genotyped by direct sequencing. All other SNPs
were genotyped with the LightCycler™ assay (Roche, Man-
nheim, Germany) based on hybridization of probes
labeled by two different dyes allowing Fluorescence Reso-
nance Energy Transfer (FRET) [33]. A genotyping quality
control was performed by introducing duplicates in the
PCR plates and by genotyping all individuals twice.
Sequences of primers and conditions of LightCycler assays
are available on request.
LD analysis
Pairwise  ∆  (correlation coefficient between identified
CART SNPs) was estimated from genotypes for the 45 sub-
jects and the results were visualized by the GOLD program
http://www.sph.umich.edu/csg/abecasis/GOLD/.
Statistical analysis for association studies
Hardy-Weinberg proportions for cases and controls were
tested by the χ 2 test. Allelic and genotypic frequencies dif-
ferences between cases and controls were assessed by χ 2. A
region-wide empirical p-value was calculated through per-
mutation. This involved the individual genotype as a
whole and the individual's status being shuffled. This
method preserves the correlation between SNPs (LD)
while breaking the relation between status and the geno-
types. For each replicate or permutation each SNP was
tested for association and the most significant p-value was
stored. We could then compare this p-value to the best
observed p-value.
For the haplotype analysis, identification of the minimal
set of SNPs that could account for the genotypic diversityBMC Genetics 2005, 6:19 http://www.biomedcentral.com/1471-2156/6/19
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was made by systematic enumeration in each block. Hap-
lotypes frequencies were calculated and, after skipping the
haplotypes with a frequency lower than 0.02, each SNP
and set of SNPs in turn were removed. Thus we found the
SNP combination that preserves the marginal haplotype
frequencies. This method is implemented in the STRAT-
EGY software. Effects of haplotype were tested using the
THESIAS (Testing Haplotype Effects in Association Studies)
software. The objective of the program is to perform hap-
lotype-based association analysis in unrelated individu-
als. This program is based on the maximum likelihood
model described in Tregouet et al. (2002) and is linked to
the SEM algorithm [18]. The effect of haplotypes with a
frequency lower than 1% was not included in the analysis.
THESIAS allows the simultaneous estimation of haplo-
type frequencies and of their effects on the phenotype of
interest. It is possible to get the log-likelihood of the data
under a specific hypothesis concerning haplotype effects
by setting some appropriate constraints on regression
parameters. The notation β (h) will refer to the regression
parameter characterizing the effect of haplotype h. This
option is useful for testing for the equality of haplotype
effects and to observe the SNP effects on a haplotype. For
example, to test the effect of the second SNP among the
four existent haplotypes, we could note two equations
β (11) = β (12) and β (21) = β (22). If the difference between glo-
bal likelihood and likelihood for tested SNP is significant,
then the SNP tested had an important role in the haplo-
type combination. Significance of the model was con-
firmed through permutation with disease. As the Hardy
Weinberg disequilibrium observed in controls could
induce errors for haplotype analysis, we tested the robust-
ness of this analysis. As a result, the permutation of status
among individuals allowed us to confirm the significance
of the result. Secondly, the analysis using the
UNPHASED/COCAPHASE program [34] on the individu-
als having unambiguous haplotypes, which does not rely
on Hardy Weinberg equilibrium hypotheses was carried
out and confirmed a strong association.
Cell line and treatment
Rat islet somatostatin-producing RIN-1027-B2 cells were
grown in Dulbecco's modified Eagles medium (DMEM)
supplemented with 10% fetal bovine serum, penicillin
(10 U/ml), streptomycin (10 mg/ml) and incubated at
37°C under a 5% CO2 atmosphere. To analyse CHOP
DNA-binding activity in stressed cells, a set of confluent
cells was treated for six hours with 2 µg/ml tunicamycin
(Sigma), as previously described [35]. Nuclear extracts
were prepared as previously described [36].
Electrophoretic Mobility Shift Assay (EMSA) experiment 
and Western blot
For EMSA, protein concentrations were determined by the
Bio-Rad protein assay with bovine serum albumin as a
standard. Double-stranded DNA probes of 23 bp (forward
strand : 5'-gctcactgcaaT/Cctctgccctgc-3') containing the -
3608T>C polymorphisms were labeled with T4 polynu-
cleotide kinase using [γ 32P]ATP, purified with the mini-
Quick Spin Columns system (Roche Applied Science,
Basel, Switzerland). The labelled probes had a specific
activity of ~1 × 106 cpm/pmol DNA. Binding reactions
were performed at least three times to replicate results and
in the presence of homologous, heterologous and unre-
lated control competitors They were carried out in a total
volume of 20 µl, containing 35000 cpm of radio labeled
probe, 10 µg of nuclear extracts, 2 µg of poly (dI-dC) and
a buffer with 20 mM potassium phosphate (pH 7.9), 70
mM KCL, 1 mM DTT, 0.3 mM EDTA and 10% glycerol.
Gels were exposed to X-ray films (Kodak, Rochester, New
York, United States). Quantitation of the label was per-
formed with the NIH Image software http://
rsb.info.nih.gov/nih-image/. Nuclear extracts were sub-
jected to SDS-Page, Western blotting and immunolabe-
ling using rabbit anti-CHOP (R-20), rabbit anti-GATA-3
(H-18) or rabbit anti-OCT-1 (C-21) polyclonal antibodies
(200 µg/ml) from Santa Cruz Biotechnology, Inc., Califor-
nia, U.S.A. When EMSA was performed with antibodies,
the binding mix (listed above) was incubated with anti-
body for 30 min; where after the radiolabeled probe was
incubated for 30 min.
List of abbreviations
ARC, arcuate nucleus; CART, cocaine and amphetamine
regulated transcript; CHOP/GADD153 (C/EBP homolo-
gous protein 10); CI, confidence interval; GATA-3, GATA-
binding protein 3; OCT-1, octamer-binding transcription
factor 1 ; EMSA, electrophoretic mobility shift assay; FRET,
fluorescence resonance energy transfer; HWE, Hardy-
Weinberg equilibrium; ICV, intracerebroventricular injec-
tion; LD, linkage disequilibrium; NPY, neuropeptide Y;
OR, odds ratio; POMC, pro-opiomelanocortin; SNPs, sin-
gle nucleotide polymorphisms.
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